29 results
20-F/A
2022 FY
FRES
Fresh2 Group Ltd
25 Mar 24
Annual report (foreign) (amended)
4:02pm
this, it is possible that a conflict of interest could have an adverse effect on our business, financial condition and results of operations.
For more … to give rise to a conflict of interest, and sets forth relevant restrictions and procedures when a conflict of interest arises to ensure the best interest
20-F/A
2022 FY
FRES
Fresh2 Group Ltd
9 Jan 24
Annual report (foreign) (amended)
4:24pm
these transactions. Notwithstanding this, it is possible that a conflict of interest could have an adverse effect on our business, financial condition and results … that could reasonably be expected to give rise to a conflict of interest, and sets forth relevant restrictions and procedures when a conflict of interest
424B5
FRES
Fresh2 Group Ltd
6 Dec 23
Prospectus supplement for primary offering
5:23pm
reasonably be expected to give rise to a conflict of interest, and sets forth relevant restrictions and procedures when a conflict of interest arises
6-K
EX-10.1
FRES
Fresh2 Group Ltd
4 Dec 23
Report of Foreign Private Issuer
6:43am
Group Company that includes an organizational conflict of interest prohibition, restriction, representation, warranty or notice provision or any other … adverse to the continuing business interests of the Purchaser, Fresh2, any Group Company or their respective Affiliates; (iii) there is a conflict
424B5
FRES
Fresh2 Group Ltd
25 Sep 23
Prospectus supplement for primary offering
9:28am
disclose any situations that could reasonably be expected to give rise to a conflict of interest, and sets forth relevant restrictions and procedures when … a conflict of interest arises to ensure the best interest of the company.
Dissolution; Winding Up
Under the Delaware General Corporation Law, unless
6-K
EX-10.1
rjp7pmgdm3bixiht1so0
21 Jul 23
Report of Foreign Private Issuer
4:18pm
424B5
ux05pygk
4 Apr 23
Prospectus supplement for primary offering
5:23pm
424B5
h06uc6io
12 Nov 21
Prospectus supplement for primary offering
5:23pm
6-K
EX-1.1
t49xw8vp7l
12 Nov 21
AnPac Bio Announces Pricing of Approximately $2.9 Million Underwritten Public Offering of American Depositary Shares
7:00am
424B5
cih9z3wpem3knjqc
22 Jul 21
Prospectus supplement for primary offering
12:57pm
F-3
z3cii fd9bwu4kgdczr6
28 May 21
Shelf registration (foreign)
4:32pm
F-3
EX-4.4
zyxuc7gn6 0v
28 May 21
Shelf registration (foreign)
4:32pm
F-1/A
1xhbbe6h4d 970
14 Oct 20
Registration statement (foreign) (amended)
4:06pm
F-1
b2r0q b2c3
30 Sep 20
Registration statement (foreign)
4:05pm
20-F
rbclhkcwbil3dd pwf
15 May 20
Annual report (foreign)
4:14pm
20-F
EX-2.7
367pa39e4wubxal5
15 May 20
Annual report (foreign)
4:14pm
424B4
w17 qjcxcl
31 Jan 20
Prospectus supplement with pricing info
6:31am